Introduction
============

Neural stem cells (NSCs)/neural progenitor cells (NPCs) possess lifelong self-renewal abilities and can differentiate into neurons as well as glial cells such as astrocytes and oligodendrocytes in certain induced conditions ([@B19]). Neurogenesis in the adult brain remains controversial. The first evidence of adult hippocampal neurogenesis in the mammalian system was reported 50 years ago ([@B1]). However, current opinion is that neurogenesis in the hippocampus decreases rapidly during the first years of life and that neurogenesis in the dentate gyrus does not continue, or is extremely rare in adult humans ([@B58]). In contrast, another view is that human hippocampal neurogenesis from NPCs persists throughout aging ([@B4]). Regardless of this debate, we will review the mechanisms and methods of *in vitro* expansion of NSCs.

Although 21 or 20% of oxygen is considered widely as normoxia in various cell culture methods *in vitro*, physiological normoxia is 2--9% for most cell types ([@B56]). Therefore, hypoxia is actually the microenvironment for most cells, especially stem cells ([@B40]). As hypoxia maintains the undifferentiated state of stem cells, including NSCs, hematopoietic stem cells (HSCs), and mesenchymal stem cells (MSCs) ([@B36]; [@B37]; [@B60]), the proliferation, quiescence, and fate commitment of stem cells are commonly modulated by hypoxia. Moreover, stem cells have been found to reside mostly in hypoxic niches to sustain a lifelong quiescent or undifferentiated state. Cells respond to hypoxia via hypoxia-inducible factors (HIFs), which are heterodimers composed of a regulatory HIF-α subunit and a constitutive HIF-β subunit ([@B22]). In general, the effectiveness of hypoxia is mostly achieved through HIF-α. However, HIF-α is extremely unstable under normoxia because it can be degraded by the PHD-mediated ubiquitin-proteasome pathway. Inhibition of PHD activity stabilizes HIF-α and mimics the effects of hypoxia. Therefore, developing PHD inhibitors targeting HIF-α stability would be expected to achieve more specific and effective hypoxia-mimicking effects in normoxia. As mentioned above, in the nervous system, adult NSCs exist in quiescence in limited number (or are even completely absent). Neuronal transplants from NSCs cultured *in vitro* are needed for the treatment of neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease as well as conditions like stroke ([@B21]).

In this review, we present recent findings on the roles of hypoxia, HIF transcription factors and PHD inhibitors in NSC proliferation, focusing on the potential application of PHD inhibitors to mimic the effects of hypoxia.

NSC Self-Renewal/Proliferation Under Hypoxic Conditions
=======================================================

Neural stem cells have the ability to proliferate and differentiate into astrocytes, oligodendrocytes, and neurons ([@B19]). Previous studies have shown that in adult mice the main NSC niches are located in the hippocampus and the subventricular zone (SVZ), where they promote stem cell proliferation at low oxygen concentrations (1--5% O~2~) ([@B40]). Under anoxic conditions, mitochondrial respiration is inhibited and cellular energy is produced by anaerobic glycolysis, which provides insufficient energy to fully support cell proliferation ([@B41]). Indeed, mild hypoxia (2.5--5% O~2~) is the optimal condition for the proliferation of NSCs in comparison with 1 or 21% O~2~. [@B47] have recently shown that in marked contrast to 2.5--5% O~2~, 1% O~2~ decreased the proliferation of immortalized human NSCs (IhNSCs) and raised the rate of apoptosis. In comparison with IhNSCs, hNSCs were unable to proliferate in 1% O~2~, dying after a few passages, presumably because of cell cycle arrest and inhibition of transcriptional activity ([@B32]; [@B30]; [@B68]). Furthermore, [@B43] found that neural precursor proliferation in the human postnatal brain is enhanced in hypoxic conditions (5% O~2~), while raising oxygen tension to 20% depletes precursors and promotes astrocyte differentiation. Hypoxia-expanded precursors generated 17-fold more oligodendrocytes and when these precursors were expanded in hypoxia and then differentiated in normoxia, oligodendrocyte maturation was further enhanced by 2.5-fold ([@B43]). Hypoxia (5% O~2~) also reduces apoptosis while promoting the proliferation of NSCs, and WNT/β-catenin may be involved in the regulation of NSC proliferation ([@B13]). Under hypoxia (1.7% O~2~), nuclear orphan receptor TLX acts as a mediator for the proliferation and pluripotency of neural progenitors and is recruited to the *Oct-3/4* (Octamer-binding transcription factor 3/4) proximal promoter, enhancing gene transcription and promoting progenitor proliferation ([@B8]). Hypoxia/reoxygenation (H/R) is another method to stimulate NPC proliferation, via activation of the MEK (MAP kinse-ERK kinase)/ERK (extracellular signal-regulated kinase) and the PI3K (phosphoinositide-3-kinase)/AKT signaling pathways through a PKC (protein kinase C)-dependent mechanism. These signals were associated with proliferation of NPCs ([@B59]).

In addition to the effects on NSC proliferation or self-renewal capacity, hypoxia also increases their survival ability after transplantation into animals with intracerebral hemorrhage. [@B63] have demonstrated that mild hypoxia (5% O~2~, 24 h) enhanced NSC proliferation, upregulated p-AKT via HIF-1α and increased vascular endothelial growth factor (VEGF) production around the wound after transplantation, which favors survival of transplanted cells. Another study indicates that hypoxia regulates the expression of functional metabotropic glutamate receptor (mGluR) in proliferating NSCs and the dynamic expression of mGluRs induced by hypoxia may be one of the mechanisms of hypoxia-stimulated NSC activation ([@B10]). Interestingly, it has been reported that hypoxic conditioned media from rat cerebral cortical cells promotes NSC proliferation and differentiation into a high percentage of neurons, and these processes may be promoted through PI3K/AKT pathways ([@B6]).

Hypoxia also has a similar effect on neurogenesis in the animal brain. Our previous study showed that intermittent hypoxia (IH) increased NSC proliferation, newborn neuron survival and migration, spine morphogenesis in the dentate gyrus of the hippocampus, and neurogenesis in the olfactory bulb ([@B73]; [@B72]). Further evidence suggested that NOTCH1 signaling was activated following IH, which was required for hypoxia-induced neurogenesis ([@B70]). [@B46] reported another hypoxic approach to NSC expansion and neuronal differentiation. An acute (\<1 h) *in vivo* exposure to intermittent hypoxia (AIH) was conducted using neonatal C57BL/6 mice, and the isolated NPCs from SVZ tissues grew in neurospheres or adherent monolayers. AIH stimulated the proliferation of NPCs. Therefore, *in vivo* AIH exposure can enhance the viability of SVZ-derived NPC cultures *in vitro* ([@B46]). Altogether, both *in vivo* and *in vitro* hypoxia stimulation can promote NSC proliferation and a capacity for self-renewal. Since hypoxia has a wide range of effects, revealing the mechanism by which it promotes the proliferation of NSCs will contribute to targeting NSC proliferation *in vitro* and *in vivo*.

HIF-1 Transcriptional Factor Under Hypoxia
==========================================

HIF-1α is a regulatory subunit of the HIF-1 transcriptional regulator. The constitutive subunit HIF-1β is present in excess and heterodimerizes with HIF-1α or other bHLH-PAS (basic helix-loop-helix--PER--ARNT--SIM) proteins. Therefore, HIF-1α protein levels determine HIF-1 transcriptional activity ([@B53]). In addition to HIF-1α, HIF-2α was subsequently discovered, which also binds to the common HIF-1β subunit and forms the HIF-2 heterodimer ([@B62]). While the functions of HIF-1 and HIF-2 are similar, their distribution is different, with HIF-1α being ubiquitously expressed whereas HIF-2α is restricted to certain cell populations and mediates distinct functions ([@B44]). HIF-3α was originally considered as an inhibitor of HIF-1 via sequestration of HIF-1β. However, some findings indicate that HIF-3 also functions as a transcriptional activator in certain contexts such as in the hypoxic response in zebrafish embryos ([@B71]). In this article, we focus on the regulation of HIF-1 because it is the most widely studied and represented. In normoxic conditions, prolyl residues 402 and 564 in the HIF-1α oxygen-dependent degradation domain (ODD) are hydroxylated by HIF prolyl hydroxylases (PHDs) ([@B25]; [@B51]). Subsequently, the hydroxylated HIF-1α is recognized by von Hippel-Lindau protein (VHL), which is responsible for the recruitment of an ubiquitin ligase to target HIF-1α for proteasomal degradation ([@B27]). In hypoxic conditions, PHDs are inactivated and the degradation of HIF-1α is blocked. Stabilized HIF-1α constitutes a heterodimer with HIF-1β and directly binds hypoxia-responsive elements (HREs) in the promoter of downstream genes, which are thereby activated ([@B52]; [@B56]). HIF-1 activates the transcription of VEGF and erythropoietin (EPO), which encode angiogenic cytokines or growth factors, leading to angiogenesis and erythropoiesis, and so tissue perfusion improves and O~2~ delivery increases in normal tissues ([@B54]). Another study reported that mice that are homozygous for a null allele at the locus encoding HIF-1α die at embryonic day 10.5 ([@B65]). Conditional knockout of HIF-1α in specific cells unveiled its critical roles in hematopoiesis, osteogenesis, and innate immunity ([@B53]), thus highlighting its crucial role in normal development.

HIF-1 is Associated With Self-Renewal Capacity of NSCs
======================================================

Hypoxic preconditioning or exposure to sublethal levels of hypoxia enhanced NSC proliferation ([@B18]; [@B48]). Hypoxic preconditioning (5% O~2~, 24 h) may increase NSC proliferation by acting on the HIF-1α/AKT pathway. Moreover, VEGF as a downstream target of HIF-1α is released in response to hypoxia and promotes cell survival. It is critical for post-stroke cerebral cytoprotection that the transplanted stem cells have the capability to secrete VEGF ([@B63]). Hypoxia (0.5% O~2~, 36 h) also promotes the proliferation of neural crest stem cells (NCSCs), which are a population of adult multipotent stem cells through upregulating HIF-1α ([@B9]). Similarly, intermittent hypoxia (10% O~2~ for 20 cycles, 40-min duration overall) increases NPC populations within the SVZ of the lateral ventricles and in the subgranular zone of the hippocampal dentate gyrus. Further experiments *in vitro* demonstrate that intermittent hypoxia markedly enhances the capacity for expansion of a cultured neurosphere, which is accompanied by increases in a proliferation maker (Ki67), MTT activity, and HIF-1α signaling ([@B46]).

The underlying mechanisms of HIF-1-mediated NSC proliferation or self-renewal entail the transcriptional expression of VEGF via HIF-1, which in turn stimulates neurogenesis ([@B24]). Another HIF-1 target gene (EPO) also promotes proliferation of NSCs by modulating NF-kB (nuclear factor-kappa B) signaling ([@B55]). Additionally, WNT/β-catenin signaling is implicated in the effects of HIF-1α on NSC proliferation. HIF-1α deletion leads to impaired WNT/β-catenin activity in the hippocampus, with impaired NSC proliferation ([@B36]; [@B5]; [@B26]). Of note, our latest unpublished data show that autophagy induced by HIF-1 mediates NSC proliferation. Together, the above studies indicate that HIF promotes NSC self-renewal or proliferation through different signaling pathways. A number of hypoxic conditions are conducive to the self-renewal capacity of NSCs via the HIF-1 pathway. On the other hand, hypoxia does not specifically and exclusively affect NSC proliferation, due to the number of its downstream effectors, apart from the HIF-1 pathway. Furthermore, HIF-1α is unstable under normoxic conditions, and as such is easily degraded by the proteasome system ([@B44]).

Hif Ubiquitination Degradation and PHDs
=======================================

As previously mentioned, in normoxia HIF-1α is subjected to oxygen-dependent hydroxylation by the prolyl hydroxylase domain proteins PHD1-3 at its proline residues 402 and 564, which are followed by the binding of a von Hippel-Lindau protein VHL in an ubiquitin ligase complex ([@B14]; [@B27]; [@B28]; [@B66]). The resulting event is the ubiquitination and proteasomal degradation of HIF-1α. The half-life of HIF-1α is only a few minutes when exposed to 20% O~2~ under standard tissue culture conditions ([@B44]).

PHDs are recognized as "oxygen sensors" at the cellular level ([@B29]). The PHD family consists of three members, PHD1, PHD2, and PHD3, which share conserved COOH-terminal regions responsible for hydroxylase activity, while at the NH~2~-terminus they are greatly different ([@B14]). Each isoform is tissue or cell line-specific as well as subcellular specific ([@B11]). PHD1 is mainly expressed in the nuclei of the testis and liver ([@B61]), PHD2 is localized mainly in the cytoplasm in the heart and testis ([@B50]), and PHD3 has both nuclear and cytoplasmic localization mainly in the heart and liver ([@B38]). In addition, they have different regulatory patterns on the modulation of HIF-α: PHD2 is the primary regulator of HIF-1α, and although PHD3 is less active than PHD2 in regulating HIF-1α, it is more likely to target HIF-2α under hypoxic conditions ([@B2]).

The hydroxylation reaction of HIF-1α is controlled by the activity of PHDs, which is regulated by O~2~, Fe^2+^, α-ketoglutarate, and ascorbic acid ([@B29]; [@B64]). Under hypoxic conditions, when the hydroxylation reaction is inhibited due to a lack of oxygen, HIF-1α is stabilized and enters the nucleus to form the HIF-1 heterodimer with HIF-1β, which activates the transcription of 100s of target genes and leads to a synergistic adaptation to hypoxia.

It is noteworthy that the prolyl hydroxylase enzymes contain Fe^2+^ in their catalytic centers; therefore, HIF-1α can also be stabilized pharmacologically through the addition of iron chelators such as desferrioxamine (DFO) or iron antagonists such as cobalt chloride (CoCl~2~), in addition to hypoxia. Furthermore, since α-ketoglutarate is a substrate of PHDs, its competitive antagonists \[including dimethyloxalylglycine (DMOG)\] can stabilize HIF-1α ([@B14]). Additionally, multiple proteins have been identified that promote oxygen-dependent degradation of HIF-1α, for example OS9 (ortholog of fungi Yos9p) and RUNX3 (runt related transcription factor 3), which increase the efficiency of hydroxylation of HIF-1α via binding to both HIF-1α and PHD2 ([@B3]; [@B34]); and LIMD1 (LIM domains containing 1) alongside RHOBTB3 (Rho-related BTB domain-containing protein 3) can form a complex with HIF-1α, PHD2, and VHL to promote hydroxylation-mediated ubiquitination ([@B67]). In any case, PHDs play a crucial role in the instability of HIF-1α. Therefore, inhibition of PHD activity is essential for stabilizing and activating the transcriptional activity of HIF-1.

PHD Inhibitors and Proliferation of NSCs
========================================

As discussed above, the employment of hypoxia-mimetics to provide HIF-1α stabilization might facilitate the expansion of NSCs *in vitro*. However, the commonly used agents for stabilizing HIF-1α, including CoCl~2~, DFO or DMOG, not being specific inhibitors of PHD, have side effects on vital cellular processes. Some agents demonstrate cytotoxicity, spanning from long- (e.g., DFO) to short- (e.g., CoCl~2~) term, to proliferating NPCs, leading to decreased expression of cyclin D1 and nestin in MSCs ([@B35]; [@B42]; [@B39]), while others showed a combination of antiproliferative and cytotoxic effects (e.g., DMOG). However, DMOG-treated human-induced pluripotent stem cell-derived MSCs (hiPSC-MSCs) show improved expressions of HIF-1α and its downstream genes, indicating that DMOG significantly enhances the expression profiles of angiogenic-related factors in hiPSC-MSCs via maintaining HIF-1α stability. In a critical-sized calvarial defect model in rats, DMOG-treated hiPSC-MSCs showed increased angiogenic capacity in the tissue-engineered bone, which results in bone regeneration ([@B69]). However, in this study, the side effects of DMOG were not evaluated. A new selective PHD inhibitor FG-4497 has been developed, which stabilizes HIF-1α and induces the expression of HIF-1 target genes. It has been reported that FG-4497 ameliorates mucosal damage in experimental murine colitis ([@B45]). In addition, FG-4497 is also reported in HSCs to stabilize HIF-1α protein *in vivo* in the bone marrow (BM), increase the proportion of HSCs and primitive hematopoietic progenitor cells (HPCs) into quiescence, and accelerate blood recovery after severe irradiation ([@B17]). Importantly, FG-4497 promotes cell proliferation without being toxic to NPCs and increases the number of cells in normoxia, comparable to hypoxia-induced effects, and is also beneficial for dopaminergic differentiation ([@B39]). Thus, FG-4497 appears to be a non-toxic small molecule, capable of inducing neurogenesis *in vitro*.

Endogenous inhibitors such as reactive oxygen species (ROS) can also block the activity of PHDs, thereby stabilizing HIF-1α. Mitochondria are the main intracellular source of ROS ([@B57]; [@B49]). Other intracellular sources include NADPH oxidases (NOX) ([@B16]). The amount of ROS produced at a cellular level may play a key role in determining NSC fate. In one study, high levels of ROS produced by NOX activity in hypoxic conditions (4% O~2~) were associated with NSC regeneration, while low endogenous ROS levels resulted in a decrease in NSCs' capacity for self-renewal ([@B33]). The proposed mechanism entailed enhanced ROS-dependent NSC self-renewal and neurogenesis via the PI3K/AKT signaling pathway. Conversely, decreased levels of cellular ROS as a result of pharmacological or genetic manipulations were shown to interfere with NSC function *in vitro* and *in vivo* ([@B31]; [@B12]).

PHD activity is closely related to ROS levels in many systems. Relatively low levels of ROS increase PHD activity, whereas high ROS levels stabilize HIF-1α as a result of inactivating PHDs ([@B7]; [@B15]; [@B23]). However, to date, the mechanism by which ROS directly affect PHD function has not been clarified, since stabilization of HIF-1α can occur independently of mitochondrial ROS production during hypoxia, indicating that PHD activity may not be directly regulated by ROS ([@B64]). One study proposed that H~2~O~2~ may affect PHD activity more directly through a local Fenton reaction ([@B20]). Although ROS have been implicated in the regulation of PHD activity, this modulation in NSCs has not been reported. The graphical abstract reported in Figure [1](#F1){ref-type="fig"} summarizes these studies and puts forward the concept that the proliferation and differentiation of NSCs are regulated by upstream PHD activity and the core transcription factor HIF-1.

![Modulation of PHD-HIF1 signaling on neural stem cells (NSCs). Under normoxia, HIF-1α is hydroxylated by PHD at 402 and 564 residues and subsequently recognized and ubiquitinated by the E3 ligase VHL, hereafter, degraded in the proteasome. In response to hypoxia, ROS or PHD inhibitors, the activity of PHD is suppressed and the hydroxylation of HIF-1α by PHD is inhibited. As a result, the stabilized HIF-1α translocates to the nucleus and partners with HIF-1β to form a heterodimer that transcriptionally activates its downstream target genes to promote proliferation or differentiation of NSCs.](fcell-06-00169-g001){#F1}

Conclusion and Future Perspectives
==================================

As previously described, hypoxia-dependent regulation of NSC proliferation can be simulated with pharmacological interventions acting via HIF-1α stabilization. Several PHD inhibitors have the potential to promote NSC proliferation; however, their side effects hinder their use. Therefore, the development of new specific and effective PHD inhibitors may offer a valid tool for the application of NSC transplantation in neurodegenerative diseases. Additionally, targeted hypoxia-mimicking agents need to be developed specifically for neural cells for future clinical application.
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